Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial

INTRODUCTION: Systemic low-grade inflammation is a fundamental pathophysiological mechanism of heart failure with preserved left ventricular ejection fraction (HFpEF). The efficacy of anti-inflammatory therapy in HFpEF is largely understudied. The aim of the study is to assess the anti-inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Shchendrygina, Anastasia, Rachina, Svetlana, Cherkasova, Natalia, Suvorov, Aleksandr, Komarova, Irina, Mukhina, Nadezhda, Ananicheva, Natalia, Gasanova, Diana, Sitnikova, Violetta, Koposova, Aleksandra, Smirnova, Julia, Moiseewa, Elizaveta, Drogashevskaya, Daria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432645/
https://www.ncbi.nlm.nih.gov/pubmed/37586845
http://dx.doi.org/10.1136/openhrt-2023-002360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432645/
https://www.ncbi.nlm.nih.gov/pubmed/37586845
http://dx.doi.org/10.1136/openhrt-2023-002360

Ejemplares similares